Significant progress in preclinical pipeline targeting KRAS-driven solid tumor cancers with systemic administration ...

NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical-stage biotechnology company dedicated to developing novel treatments for cancer and viral infections ...

About PD-1 Inhibitors PD-1 inhibitors work by blocking the PD-1 (programmed death-1) receptor on T cells, preventing cancer cells from evading the immune system and restoring the body’s ability to ...

Significant progress in preclinical pipeline targeting KRAS-driven solid tumor cancers with systemic administration demonstrating robust anti-tumor and anti-metastasis activity in orthotopic mouse ...

Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company pioneering RNA interference ...

The researchers designed an efficient approach for fabricating engineered Pts-based nano-aircraft carriers with graded drug ...

Application of seasonal auto-regressive integrated moving average model in forecasting the incidence of hand-foot-mouth disease in Wuhan, China. 'Outbreak Gold Standard' selection to provide ...

Cancer models are naturally existing or artificially induced systems that share features with human cancers. Experimental systems for studying human cancer include cell lines and organisms such as ...

After hours: March 14 at 7:58:54 p.m. EDT Loading Chart for SLXN ...